PD GENEration Now Includes 20+ Clinical Sites, Aims to Enroll 15,000
The Parkinson’s Foundation has announced a major expansion of its PD GENEration national study to make genetic testing…
Articles by Patricia Inácio, PhD
AI Platform Shows Potential in Diagnosing Patients at Early Stages
PreciseDx’s artificial intelligence (AI) platform shows an ability to accurately diagnose Parkinson’s disease in people before they develop severely…
Riverside Health & Rehabilitation Center Opens Parkinson’s Program
The Riverside Health & Rehabilitation Center, an affiliate of National Health Care Associates, now has a comprehensive…
PolyCore Advances PCT-3012 to Treat Parkinson’s Without Dyskinesia
PolyCore Therapeutics has secured a seed investment to advance its lead compound PCT-3012, designed to treat motor symptoms in…
MJFF $4.8M Grant Will Support Work Targeting Brain Inflammation
Neuropore Therapies has received a $4.8 million grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop…
MJFF $4.9M Grant Advances Work Into Mitochondria as Therapy Target
Lucy Therapeutics (LucyTx) has received a $4.9 million, two-year grant from the Michael J. Fox Foundation…
MJFF Names German Neurologist as Winner of 2022 Langston Award
The Michael J. Fox Foundation (MJFF) has named Brit Mollenhauer, MD, a foundation scientific advisor, as the winner…
Tai Chi Improves Motor Function in Early-stage Parkinson’s: Study
Practicing tai chi for a year improved gait and balance in early-stage Parkinson’s disease patients, improving both inflammation and…
MyoExo Sensors Remotely Measure Muscle Strain, Bulging
Scientists have created a set of sensors that can help measure muscle strain and bulging while integrated in a wearable device,…
CVN424 Shows Promise as Levodopa Add-on Therapy, Phase 2 Data Show
Using Cerevance’s oral CVN424 as an add-on therapy for Parkinson’s motor symptoms led to a significant and meaningful…